Cell type-programmable genome editing with enveloped delivery vehicles
Hamilton, J. R.; Chen, E.; Perez, B. S.; Sandoval Espinoza, C. R.; Doudna, J. A.
Show abstract
Viruses and virally-derived particles have the intrinsic capacity to deliver molecules to cells, but the difficulty of readily altering cell-type selectivity has hindered their use for therapeutic delivery. Here we show that cell surface marker recognition by antibody fragments displayed on membrane-derived particles encapsulating CRISPR-Cas9 protein and guide RNA can target genome editing tools to specific cells. These Cas9-packaging enveloped delivery vehicles (Cas9-EDVs), programmed with different displayed antibody fragments, confer genome editing in target cells over bystander cells in mixed cell populations both ex vivo and in vivo. This strategy enabled the generation of genome-edited chimeric antigen receptor (CAR) T cells in humanized mice, establishing a new programmable delivery modality with widespread therapeutic utility. One-Sentence SummaryCell-specific molecular delivery with enveloped delivery vehicles (EDVs) enables genome editing ex vivo and in vivo.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Directed Evolution of Genetically Encoded LYTACs for Cell-Mediated Delivery 95%
- Memory B cell Development in Response to mRNA SARS-CoV-2 and Nanoparticle Immunization in Mice 95%
- Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain 94%
Similar papers in this journal
- In vivo engineered B cells retain memory and secrete high titers of anti-HIV antibodies in mice 95%
- Multiplexed inhibition of immunosuppressive genes with Cas13d for on-demand combinatorial cancer immunotherapy 93%
- Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system 92%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein 95%
- Packaged delivery of CRISPR-Cas9 ribonucleoproteins accelerates genome editing 95%
- Anticodon Edited Transfer RNAs (ACE-tRNAs) Encoded as Therapeutic Nonviral Minimal DNA Vectors 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.